AbbVie Scores First Full Bellwether Win in AndroGel Lawsuits

Drug Industry Daily
A A
A Chicago jury found AbbVie not liable for an Arizona man’s pulmonary embolism that he blamed on AndroGel, the company’s testosterone replacement drug.

To View This Article:

Login

Subscribe To Drug Industry Daily